Calidi Bio - Wutah pendapatan triwulanan CLDI

Logo korporat perusahaan Calidi Bio (CLDI)

Geopolitical instability and sanctions are disrupting biomaterial logistics, hindering the global tests of Calidi Biotherapeutics (CLDI). The company's prospects rely on the success of the NeuroNova platform in treating solid tumors and partnerships with pharmaceutical behemoths. However, liquidity shortages and high R&D costs are creating financial pressure. The quarterly revenue growth rate reflects the business dynamics, where the parameter value reaches 0.00.

CLDI (Calidi Bio) riwayat Wutah dodolan kuartal marang kuartal saka 21.02.2024 nganti 20.11.2026

Rincian analitis perusahaan Calidi Bio (CLDI)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:Calidi Biotherapeutics (CLDI)
Barang unggulan Calidi Biotherapeutics Inc.

Calidi Biotherapeutics (CLDI) is developing innovative oncolytic virotherapy, utilizing stem cells to bypass the immune barrier when destroying tumors. The daily recalculated quarterly revenue change metric allows investors to instantly detect deviations in actual cash flows from market expectations, which is critical for assessing the commercialization of the unique virus delivery technology and determining the fundamental stability of the biotech asset.

Pesaing Calidi Biotherapeutics

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|Tingkat wutah dodolan sajrone kuartal TuHURA Biosciences|Wutah pendapatan kuartal marang kuartal Protara Therapeutics TARA|Fate Therapeutics (FATE) - Tingkat wutah pendapatan sajrone kuartal|WHWK - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal TScan Therapeutics Inc|championsoncology.com (CSBR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal XBIT|Wutah dodolan triwulanan CVM|Wutah dodolan kuartal marang kuartal OSTX (OS Therapies Incorporated)|Wutah pendapatan triwulanan RADX|ARTV: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan ANL (Adlai Nortye Ltd)|VERU - Wutah dodolan triwulanan|tempesttx.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan XLO (xiliotx.com)|RENB: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Mural Oncology plc|Wutah pendapatan kuartal marang kuartal Kairos Pharma Inc|OKUR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan GDTC|CRIS (Curis) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal apollomicsinc.com APLM|THAR: Wutah dodolan kuartal marang kuartal|advanbiomed.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan GNPX (Genprex, Inc)|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)